Redwood City, CA (PRWEB) July 30, 2013
Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced that they have added to their Series B financing round with $1.75M in additional funding, bringing their total Series B round to $8M. The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners (CNTP) and Jerry Yang at AME Cloud Ventures.
Today, new data-driven advancements in healthcare continue to gain investor interest for their potential to increase the quality and decrease the cost of healthcare. Moreover, increasing access to fast, accurate and scalable genomic analysis through early, strategic investment is at the forefront of new innovations across the healthcare system, enabling more personalized medical treatments to patients downstream.
“We are at a pivotal time in the field of genomic analysis as the availability and amount of data grows exponentially,” said Narges Bani Asadi, CEO of Bina Technologies. “We chose to seek investment from Columbus Nova and ACM Cloud Ventures because each of them understand this data-driven reality and the disruptive changes that will soon occur in our health system because of it. Bina is building the comprehensive platform to allow researchers and clinicians to extract meaningful insights from this data, and we are thrilled to be working with such premier life sciences and technology investors that understand and support the power of the genomics revolution.”
This new capital will help further Bina’s mission to become a more integrated genomic analysis platform company and unlock the potential of DNA-based medicine and biotechnology by delivering fast, accurate and scalable genomic analysis.
“As the global scientific community seeks new approaches for the treatment and prevention of disease, large-scale genomic
Copyright©2012 Vocus, Inc.
All rights reserved